Data from: Alkaline phosphatase, lactic dehidrogenase, inflammatory variables and apparent diffusion coefficients from MRI for prediction of chemotherapy response in osteosarcoma
Background. This present study aimed to assess if clinical, laboratory and MRI were an accurate benchmark in assessing the effectiveness of neoadjuvant chemotherapy in osteosarcoma patients. Methods. This was an observational analytic study with a cross-sectional design. Research subjects were selec...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Dataset |
Sprache: | eng |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background. This present study aimed to assess if clinical, laboratory and
MRI were an accurate benchmark in assessing the effectiveness of
neoadjuvant chemotherapy in osteosarcoma patients. Methods. This was an
observational analytic study with a cross-sectional design. Research
subjects were selected using the total sampling method from osteosarcoma
patients who underwent neoadjuvant chemotherapy during the period between
January 2017– July 2019. Results.Of the 58 patients included in this
study, 38 were male and 20 were female aged 5 - 67 years
(mean,16-year-old. 37(63.8%) patients underwent neoadjuvant chemotherapy
with CAI regimens and 13 (36.2%) with CA. The tumors were classified as
stage IIB in 43 (74.1%) patients and stage III in15 (25.9%) patients.
After undergoing neoadjuvant chemotherapy, 4 patients had poor MSTS, 30
patients had fair MSTS, 17 and 7 patients had good and excellent MSTS
score, respectively. Spearman’s test revealed no correlation between tumor
necrosis after neoadjuvant chemotherapy with a reduction in tumor size and
MSTS score. Wilcoxon test showed significant differences between ALP, ESR,
and NLR before and after neoadjuvant chemotherapy in the poor-response
group. We found no significant difference between LDH and LMR before and
after neoadjuvant chemotherapy in the good-response group. We had 9
patients for ADC value only. No significant statistical differences were
found in tumor volumes after chemotherapy in both groups. Conclusion. We
demonstrated that ALP level after neoadjuvant chemotherapy was markedly
decreased, and was statistically significant in the poor-response group.
We also demonstrated that LDH value before neoadjuvant chemotherapy had a
strong correlation with degree of necrosis and could be used as a
predictive indicator. NLR and LMR cannot be independent prognostic
factors. MRI plays an important role in evaluating tumor volumes and
preoperative radiological changes, using DWI and water diffusion to
predict histological necrosis. |
---|---|
DOI: | 10.5061/dryad.n8pk0p2sj |